XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
SVS Shares (as converted)
Share Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings (Deficit)
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021   324,312,662        
Beginning balance at Dec. 31, 2021 $ 1,481,806   $ 1,535,765 $ 0 $ (55,235) $ 1,276
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   771,337        
Share-based compensation 11,742   11,742      
Issuance of shares in conjunction with acquisitions (in shares)   1,403,067        
Issuance of shares in conjunction with acquisitions 13,220   13,220      
Non-controlling interest adjustment for change in ownership (1,567)         (1,567)
Contingent consideration & other adjustments to purchase accounting (in shares)   1,381,332        
Contingent consideration & other adjustments to purchase accounting 17,505   17,505      
Net income (loss) 77       (214) 291
Ending balance (in shares) at Mar. 31, 2022   327,868,398        
Ending balance at Mar. 31, 2022 1,522,783   1,578,232 0 (55,449) 0
Beginning balance (in shares) at Dec. 31, 2022   339,983,374        
Beginning balance at Dec. 31, 2022 1,341,550   1,665,957 (8) (324,399) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   117,948        
Share-based compensation 506   506      
Issuance of shares to relieve liability obligations, net (in shares)   603,396        
Issuance of shares to relieve liability obligations, net 3,653   3,653      
Foreign currency translation adjustment (1)     (1)    
Contingent consideration & other adjustments to purchase accounting (in shares)   1,625,546        
Net income (loss) (9,237)       (9,237)  
Ending balance (in shares) at Mar. 31, 2023   342,330,264        
Ending balance at Mar. 31, 2023 $ 1,336,471   $ 1,670,116 $ (9) $ (333,636) $ 0